An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2025-150/coif). J.G., S.S.M., and R.J.K. report that this work was supported by grants from the National Institutes of Health (grant Nos. UH3 DE030431 and R34 DE033042). The other author has no conflicts of interest to declare.
Jakobsen KK, Carlander AF, Todsen T, Melchiors J, Paaske N, Østergaard Madsen AK, Kloch Bendtsen S, Mordhorst C, Stampe H, Kastrup J, Ekblond A, Haack-Sørensen M, Farhadi M, Maare C, Friborg J, Lynggaard CD, Werner Hauge A, Christensen R, Grønhøj C, von Buchwald C.Jakobsen KK, et al.Clin Cancer Res. 2024 May 15;30(10):2078-2084. doi: 10.1158/1078-0432.CCR-23-3675.Clin Cancer Res. 2024.PMID: 38441659Free PMC article.Clinical Trial.
References
Jakobsen KK, Carlander AF, Todsen T, et al. Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial. Clin Cancer Res 2024;30:2078-84. 10.1158/1078-0432.CCR-23-3675
-
DOI
-
PMC
-
PubMed
Grønhøj C, Jensen DH, Vester-Glowinski P, et al. Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX). Int J Radiat Oncol Biol Phys 2018;101:581-92. 10.1016/j.ijrobp.2018.02.034
-
DOI
-
PubMed
Lynggaard CD, Grønhøj C, Christensen R, et al. Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II). Stem Cells Transl Med 2022;11:478-89. 10.1093/stcltm/szac011
-
DOI
-
PMC
-
PubMed
Chinnadurai R, Copland IB, Patel SR, et al. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells. J Immunol 2014;192:1491-501. 10.4049/jimmunol.1301828
-
DOI
-
PubMed
Chinnadurai R, Copland IB, Garcia MA, et al. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing. Stem Cells 2016;34:2429-42. 10.1002/stem.2415
-
DOI
-
PMC
-
PubMed